Lineage Cell Therapeutics Inc (NY: LCTX )
0.8023
-0.0271
(-3.27%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 14, 2024
Add to My Watchlist
All News about Lineage Cell Therapeutics Inc
![](https://investorplace.com/wp-content/uploads/2022/07/growth-stocks-plant-coins.png)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2990.jpeg?width=1200&height=800&fit=crop)
Lineage Cell Therapeutics Earnings Perspective: Return On Capital Employed
September 07, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20220815005164/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_767.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2641.jpeg)
![](https://mms.businesswire.com/media/20220811005126/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220804005025/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/08/laboratory-563423_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_15696.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220602005379/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6491.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220512005185/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/12/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_3036.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220505005147/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/02/biotech7.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20220503005172/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220426005359/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220425005336/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220413005356/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220411005035/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/image_4_22.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/image_5_25.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220324005234/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220321005294/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_672.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2705.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1399.jpeg)
![](https://mms.businesswire.com/media/20220314005160/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.